451 related articles for article (PubMed ID: 25974737)
21. The angiotensin type 2 receptor in the human adrenocortical zona glomerulosa and in aldosterone-producing adenoma: low expression and no functional role.
Vanderriele PE; Caroccia B; Seccia TM; Piazza M; Lenzini L; Torresan F; Iacobone M; Unger T; Rossi GP
Clin Sci (Lond); 2018 Mar; 132(6):627-640. PubMed ID: 29436482
[TBL] [Abstract][Full Text] [Related]
22. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
[No Abstract] [Full Text] [Related]
23. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism.
Boulkroun S; Samson-Couterie B; Dzib JF; Lefebvre H; Louiset E; Amar L; Plouin PF; Lalli E; Jeunemaitre X; Benecke A; Meatchi T; Zennaro MC
Hypertension; 2010 Nov; 56(5):885-92. PubMed ID: 20937967
[TBL] [Abstract][Full Text] [Related]
24. Expression of aldosterone synthase and adrenocorticotropic hormone receptor in adrenal incidentalomas from normotensive and hypertensive patients: Distinguishing subclinical or atypical primary aldosteronism from adrenal incidentaloma.
Cao CX; Yang XC; Gao YX; Zhuang M; Wang KP; Sun LJ; Wang XS
Int J Mol Med; 2012 Dec; 30(6):1396-402. PubMed ID: 23023242
[TBL] [Abstract][Full Text] [Related]
25. Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas.
Fallo F; Pezzi V; Barzon L; Mulatero P; Veglio F; Sonino N; Mathis JM
Eur J Endocrinol; 2002 Dec; 147(6):795-802. PubMed ID: 12457455
[TBL] [Abstract][Full Text] [Related]
26. 18-Oxocortisol: A journey.
Gomez-Sanchez CE; Gomez-Sanchez EP
J Steroid Biochem Mol Biol; 2023 Jun; 230():106291. PubMed ID: 36921907
[TBL] [Abstract][Full Text] [Related]
27. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance.
Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
J Clin Endocrinol Metab; 2000 Jun; 85(6):2160-6. PubMed ID: 10852446
[TBL] [Abstract][Full Text] [Related]
28. Familial hyperaldosteronism.
Torpy DJ; Stratakis CA; Chrousos GP
Braz J Med Biol Res; 2000 Oct; 33(10):1149-55. PubMed ID: 11004715
[TBL] [Abstract][Full Text] [Related]
29. Clinical and Steroidogenic Characteristics of Aldosterone-Producing Adenomas With ATPase or CACNA1D Gene Mutations.
Kitamoto T; Suematsu S; Yamazaki Y; Nakamura Y; Sasano H; Matsuzawa Y; Saito J; Omura M; Nishikawa T
J Clin Endocrinol Metab; 2016 Feb; 101(2):494-503. PubMed ID: 26606680
[TBL] [Abstract][Full Text] [Related]
30. Genetic and epigenetic analyses of aldosterone-producing adenoma with hypercortisolemia.
Kometani M; Yoneda T; Demura M; Aono D; Gondoh Y; Karashima S; Nishimoto K; Yasuda M; Horike SI; Takeda Y
Steroids; 2019 Nov; 151():108470. PubMed ID: 31400391
[TBL] [Abstract][Full Text] [Related]
31. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors.
Azizan EA; Lam BY; Newhouse SJ; Zhou J; Kuc RE; Clarke J; Happerfield L; Marker A; Hoffman GJ; Brown MJ
J Clin Endocrinol Metab; 2012 May; 97(5):E819-29. PubMed ID: 22442279
[TBL] [Abstract][Full Text] [Related]
32. New genetic insights in familial hyperaldosteronism.
Jackson RV; Lafferty A; Torpy DJ; Stratakis C
Ann N Y Acad Sci; 2002 Sep; 970():77-88. PubMed ID: 12381543
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic consequences of variation across the aldosterone synthase and 11-beta hydroxylase locus in a hypertensive cohort: data from the MRC BRIGHT Study.
Freel EM; Ingram M; Friel EC; Fraser R; Brown M; Samani NJ; Caulfield M; Munroe P; Farrall M; Webster J; Clayton D; Dominiczak AF; Davies E; Connell JM
Clin Endocrinol (Oxf); 2007 Dec; 67(6):832-8. PubMed ID: 17651452
[TBL] [Abstract][Full Text] [Related]
34. Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.
Omata K; Satoh F; Morimoto R; Ito S; Yamazaki Y; Nakamura Y; Anand SK; Guo Z; Stowasser M; Sasano H; Tomlins SA; Rainey WE
Hypertension; 2018 Oct; 72(4):874-880. PubMed ID: 30354720
[TBL] [Abstract][Full Text] [Related]
35. Aldosterone-Regulating Receptors and Aldosterone-Driver Somatic Mutations.
Lim JS; Plaska SW; Rege J; Rainey WE; Turcu AF
Front Endocrinol (Lausanne); 2021; 12():644382. PubMed ID: 33796077
[TBL] [Abstract][Full Text] [Related]
36. High Prevalence of Primary Aldosteronism in Patients with Type 2 Diabetes Mellitus and Hypertension.
Tyfoxylou E; Voulgaris N; Gravvanis C; Vlachou S; Markou A; Papanastasiou L; Tentolouris N; Kassi E; Kaltsas G; Chrousos GP; Piaditis GP
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140406
[TBL] [Abstract][Full Text] [Related]
37. Genetics of mineralocorticoid excess: an update for clinicians.
Zennaro MC; Rickard AJ; Boulkroun S
Eur J Endocrinol; 2013 Jul; 169(1):R15-25. PubMed ID: 23610123
[TBL] [Abstract][Full Text] [Related]
38. Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases.
Médeau V; Moreau F; Trinquart L; Clemessy M; Wémeau JL; Vantyghem MC; Plouin PF; Reznik Y
Clin Endocrinol (Oxf); 2008 Jul; 69(1):20-8. PubMed ID: 18284637
[TBL] [Abstract][Full Text] [Related]
39. NEFM (Neurofilament Medium) Polypeptide, a Marker for Zona Glomerulosa Cells in Human Adrenal, Inhibits D1R (Dopamine D1 Receptor)-Mediated Secretion of Aldosterone.
Maniero C; Garg S; Zhao W; Johnson TI; Zhou J; Gurnell M; Brown MJ
Hypertension; 2017 Aug; 70(2):357-364. PubMed ID: 28584012
[TBL] [Abstract][Full Text] [Related]
40. Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.
Lee IS; Kim SY; Jang HW; Kim MK; Lee JH; Lee YH; Jo YS
J Korean Med Sci; 2010 Sep; 25(9):1379-83. PubMed ID: 20808686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
